In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Series E round brings $85.4mm to Sutro Biopharma

Executive Summary

Sutro Biopharma Inc. (oncology) raised $85.4mm through its Series E round. Samsara BioCapital and Surveyor Capital co-led and were joined by existing backers Alta Partners, Amgen Ventures, Celgene, Lilly Ventures, Skyline Ventures, and SV Health Investors, as well as new investors Eventide, Nexthera Capital, Vida Ventures, and funds managed by Tekla Capital Management.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Synthesis Technologies, Production Processes
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register